From fate to tragedy: The changing meanings of life, death, and AIDS

Peter A. Selwyn, Robert Arnold

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

The advent of highly active antiretroviral therapy (HAART) and quantitative viral load assays has revolutionized the care of HIV-infected patients. However, this paradigm shift has also had unexpected, sometimes adverse consequences that are not always obvious. Before antiretroviral therapy, physicians learned how to accompany patients through their illness; to bear witness to sickness and dying; and to help patients and their families with suffering closure, and legacy. Since we have become better at treating the virus, a new temptation has emerged to dwell on quantitative aspects of HIV management and monitoring, although the skills that we learned earlier in the epidemic are no less necessary for providing good care. Our new-found therapeutic capabilities should not distract us from the sometimes more difficult and necessary task of simply 'being there' for patients for whom HAART is no longer effective. The definition and practice of end-of- life care for patients with AIDS will continue to evolve AIDS comes to resemble other chronic, treatable, but ultimately fatal illnesses, such as end-stage pulmonary disease and metastatic cancer, in which clinicians must continually readdress with their patients the balance of curative and palliative interventions as the disease process unfolds over time. The coming challenge in HIV care will be to encourage the maintenance of a 'primary care' mentality-with attention to the larger psychosocial tissues, and-of- life care, bereavement, and a focus on the patient as opposed to the illness- alongside our new antiretroviral paradigm. Otherwise, we run the risk of forgetting what we learned about healing, from a disease that we could not cure.

Original languageEnglish (US)
Pages (from-to)899-902
Number of pages4
JournalAnnals of Internal Medicine
Volume129
Issue number11
StatePublished - Dec 1 1998
Externally publishedYes

Fingerprint

Acquired Immunodeficiency Syndrome
Highly Active Antiretroviral Therapy
HIV
Hospice Care
Terminal Care
Viral Load
Lung Diseases
Primary Health Care
Maintenance
Viruses
Physicians
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

From fate to tragedy : The changing meanings of life, death, and AIDS. / Selwyn, Peter A.; Arnold, Robert.

In: Annals of Internal Medicine, Vol. 129, No. 11, 01.12.1998, p. 899-902.

Research output: Contribution to journalArticle

@article{3fe83931c02143e6b2f337eb6f86bc6c,
title = "From fate to tragedy: The changing meanings of life, death, and AIDS",
abstract = "The advent of highly active antiretroviral therapy (HAART) and quantitative viral load assays has revolutionized the care of HIV-infected patients. However, this paradigm shift has also had unexpected, sometimes adverse consequences that are not always obvious. Before antiretroviral therapy, physicians learned how to accompany patients through their illness; to bear witness to sickness and dying; and to help patients and their families with suffering closure, and legacy. Since we have become better at treating the virus, a new temptation has emerged to dwell on quantitative aspects of HIV management and monitoring, although the skills that we learned earlier in the epidemic are no less necessary for providing good care. Our new-found therapeutic capabilities should not distract us from the sometimes more difficult and necessary task of simply 'being there' for patients for whom HAART is no longer effective. The definition and practice of end-of- life care for patients with AIDS will continue to evolve AIDS comes to resemble other chronic, treatable, but ultimately fatal illnesses, such as end-stage pulmonary disease and metastatic cancer, in which clinicians must continually readdress with their patients the balance of curative and palliative interventions as the disease process unfolds over time. The coming challenge in HIV care will be to encourage the maintenance of a 'primary care' mentality-with attention to the larger psychosocial tissues, and-of- life care, bereavement, and a focus on the patient as opposed to the illness- alongside our new antiretroviral paradigm. Otherwise, we run the risk of forgetting what we learned about healing, from a disease that we could not cure.",
author = "Selwyn, {Peter A.} and Robert Arnold",
year = "1998",
month = "12",
day = "1",
language = "English (US)",
volume = "129",
pages = "899--902",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "11",

}

TY - JOUR

T1 - From fate to tragedy

T2 - The changing meanings of life, death, and AIDS

AU - Selwyn, Peter A.

AU - Arnold, Robert

PY - 1998/12/1

Y1 - 1998/12/1

N2 - The advent of highly active antiretroviral therapy (HAART) and quantitative viral load assays has revolutionized the care of HIV-infected patients. However, this paradigm shift has also had unexpected, sometimes adverse consequences that are not always obvious. Before antiretroviral therapy, physicians learned how to accompany patients through their illness; to bear witness to sickness and dying; and to help patients and their families with suffering closure, and legacy. Since we have become better at treating the virus, a new temptation has emerged to dwell on quantitative aspects of HIV management and monitoring, although the skills that we learned earlier in the epidemic are no less necessary for providing good care. Our new-found therapeutic capabilities should not distract us from the sometimes more difficult and necessary task of simply 'being there' for patients for whom HAART is no longer effective. The definition and practice of end-of- life care for patients with AIDS will continue to evolve AIDS comes to resemble other chronic, treatable, but ultimately fatal illnesses, such as end-stage pulmonary disease and metastatic cancer, in which clinicians must continually readdress with their patients the balance of curative and palliative interventions as the disease process unfolds over time. The coming challenge in HIV care will be to encourage the maintenance of a 'primary care' mentality-with attention to the larger psychosocial tissues, and-of- life care, bereavement, and a focus on the patient as opposed to the illness- alongside our new antiretroviral paradigm. Otherwise, we run the risk of forgetting what we learned about healing, from a disease that we could not cure.

AB - The advent of highly active antiretroviral therapy (HAART) and quantitative viral load assays has revolutionized the care of HIV-infected patients. However, this paradigm shift has also had unexpected, sometimes adverse consequences that are not always obvious. Before antiretroviral therapy, physicians learned how to accompany patients through their illness; to bear witness to sickness and dying; and to help patients and their families with suffering closure, and legacy. Since we have become better at treating the virus, a new temptation has emerged to dwell on quantitative aspects of HIV management and monitoring, although the skills that we learned earlier in the epidemic are no less necessary for providing good care. Our new-found therapeutic capabilities should not distract us from the sometimes more difficult and necessary task of simply 'being there' for patients for whom HAART is no longer effective. The definition and practice of end-of- life care for patients with AIDS will continue to evolve AIDS comes to resemble other chronic, treatable, but ultimately fatal illnesses, such as end-stage pulmonary disease and metastatic cancer, in which clinicians must continually readdress with their patients the balance of curative and palliative interventions as the disease process unfolds over time. The coming challenge in HIV care will be to encourage the maintenance of a 'primary care' mentality-with attention to the larger psychosocial tissues, and-of- life care, bereavement, and a focus on the patient as opposed to the illness- alongside our new antiretroviral paradigm. Otherwise, we run the risk of forgetting what we learned about healing, from a disease that we could not cure.

UR - http://www.scopus.com/inward/record.url?scp=0032401670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032401670&partnerID=8YFLogxK

M3 - Article

C2 - 9867733

AN - SCOPUS:0032401670

VL - 129

SP - 899

EP - 902

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 11

ER -